In Vitro Enzymatic and Kinetic Studies, and In Silico Drug-Receptor Interactions, and Drug-Like Profiling of the 5-Styrylbenzamide Derivatives as Potential Cholinesterase and β-Secretase Inhibitors with Antioxidant Properties

The 5-(styryl)anthranilamides were transformed into the corresponding 5-styryl-2-(p-tolylsulfonamido)benzamide derivatives. These 5-styrylbenzamide derivatives were evaluated through enzymatic assays in vitro for their capability to inhibit acetylcholinesterase (AChE), butyrylcholinesterase (BChE),...

Descripción completa

Detalles Bibliográficos
Autores principales: Mphahlele, Malose J., Agbo, Emmanuel N., More, Garland K., Gildenhuys, Samantha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145986/
https://www.ncbi.nlm.nih.gov/pubmed/33922328
http://dx.doi.org/10.3390/antiox10050647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145986/
https://www.ncbi.nlm.nih.gov/pubmed/33922328
http://dx.doi.org/10.3390/antiox10050647

Ejemplares similares